We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Avg Time Held
3.4
years
Top 10 Avg Time Held
3.7
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.7% |
| 2 | Healthcare | 23.28% |
| 3 | Industrials | 16.25% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Lowe's Companies
LOW
$112B
| $3.6M | ﹤0.01% |
41,000
-206,700
| -83% | -$19.6M |
2016 Q1
8 quarters
|
|
|
CRAY
252
DELISTED
Cray, Inc.
CRAY
| $3.37M | ﹤0.01% |
163,000
| – | – |
2014 Q3
14 quarters
|
|
253
DELISTED
Adverum Biotechnologies
ADVM
| $2.92M | ﹤0.01% |
50,340
| – | – |
2014 Q3
14 quarters
|
|
|
HABT
254
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $2.87M | ﹤0.01% |
326,000
| – | – |
2017 Q1
4 quarters
|
|
255
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.83M | ﹤0.01% |
16,500
| – | – |
2017 Q3
2 quarters
|
|
256
Armstrong World Industries
AWI
$7.17B
| $2.65M | ﹤0.01% |
47,000
| – | – |
2016 Q4
5 quarters
|
|
257
Burlington
BURL
$16.5B
| $2.64M | ﹤0.01% |
+19,800
| New | +$2.45M |
2018 Q1
0 quarters
|
|
258
Magnite
MGNI
$3.5B
| $2.4M | ﹤0.01% |
1,332,800
| – | – |
2015 Q2
11 quarters
|
|
|
GTT
259
DELISTED
GTT Communications, Inc.
GTT
| $2.27M | ﹤0.01% |
40,000
| – | – |
2017 Q4
1 quarter
|
|
260
Greif Class B
GEF.B
$4.22B
| $2.04M | ﹤0.01% |
35,000
| – | – |
2013 Q2
19 quarters
|
|
261
Signet Jewelers
SIG
$4.56B
| $1.97M | ﹤0.01% |
51,036
-4,964
| -9% | -$247K |
2016 Q4
5 quarters
|
|
262
DELISTED
Skechers
SKX
| $1.94M | ﹤0.01% |
50,000
| – | – |
2016 Q4
5 quarters
|
|
263
Roku
ROKU
$23.1B
| $1.88M | ﹤0.01% |
60,282
-11,718
| -16% | -$482K |
2017 Q3
2 quarters
|
|
264
Park Hotels & Resorts
PK
$3.25B
| $1.8M | ﹤0.01% |
66,800
| – | – |
2017 Q1
4 quarters
|
|
|
SIOX
265
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.57M | ﹤0.01% |
148,038
-172,875
| -54% | -$2.78M |
2015 Q2
11 quarters
|
|
266
McDonald's
MCD
$172B
| $1.56M | ﹤0.01% |
10,000
| – | – |
2016 Q1
8 quarters
|
|
267
Arista Networks
ANET
$228B
| $1.54M | ﹤0.01% |
96,800
+4,000
| +4% | +$67.4K |
2014 Q2
15 quarters
|
|
268
Ingevity
NGVT
$2.44B
| $1.5M | ﹤0.01% |
20,300
| – | – |
2017 Q4
1 quarter
|
|
269
Hilton Grand Vacations
HGV
$2.85B
| $1.5M | ﹤0.01% |
34,760
| – | – |
2017 Q1
4 quarters
|
|
270
AbbVie
ABBV
$505B
| $1.32M | ﹤0.01% |
14,000
| – | – |
2013 Q2
19 quarters
|
|
271
Controladora Vuela Compania de Aviacion
VLRS
$700M
| $1.16M | ﹤0.01% |
142,000
| – | – |
2013 Q4
17 quarters
|
|
|
CERN
272
DELISTED
Cerner Corp
CERN
| $1.13M | ﹤0.01% |
19,400
| – | – |
2013 Q2
19 quarters
|
|
273
Prestige Consumer Healthcare
PBH
$2.35B
| $877K | ﹤0.01% |
26,000
| – | – |
2017 Q4
1 quarter
|
|
274
AdvanSix
ASIX
$446M
| $602K | ﹤0.01% |
17,320
| – | – |
2016 Q4
5 quarters
|
|
275
Performance Food Group
PFGC
$15.4B
| $254K | ﹤0.01% |
8,500
| – | – |
2017 Q2
3 quarters
|
|
Similar funds
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.